Prognostic Value of Pre-Treatment Systemic Inflammatory Markers in Pediatric Unilateral Wilms Tumor
Cancers · 07.07.2026 · 18 (13) · 2179
DOI: 10.3390/cancers18132179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 07.07.2026. Verfasst von Hadeel Halalsheh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, King Hussein Cancer Center, Amman 11941, Jordan. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Systemic inflammation has been implicated in prognosis of multiple malignancies, yet evidence regarding its role in Wilms Tumor (WT) remains scarce. We investigated the prognostic significance of pre-treatment inflammatory markers in unilateral WT.
Methods
We conducted a retrospective analysis of children with unilateral WT treated at our institution between November 2014 and December 2023. Clinical characteristics, treatment, and outcomes were evaluated. Inflammatory markers included a novel pan-immune-inflammation value (PIV), neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR). Optimal cut-off values for Event-Free Survival (EFS) and Overall survival (OS) were determined using data-derived optimization to maximize survival curve separation (surv_cutpoint). Cox proportional hazards models were used for survival analysis, while ROC curves were used to calculate AUC values and confirm optimal cut-off points.
Results
We included 91 patients (median age: 3.6 years; 62% female), of whom 34% presented with metastasis. Higher EFS was significantly associated with low PIV (cut-off 288.9), low NLR (cut-off 1.1), and high LMR (cut-off 6.3). Similarly, OS was positively associated with lower PIV (HR 8.56 for high PIV, p = 0.038) and lower NLR (HR 4.63 for high NLR, p = 0.043). ROC analysis confirmed their discriminative ability; when evaluated at the unified survival cutpoints, LMR yielded an AUC of 0.692 for 5-year mortality (at cut-off 6.3), while NLR yielded an AUC of 0.671 for 5-year events (at cut-off 1.1).
Conclusions
Pre-treatment inflammatory markers demonstrate significant prognostic value in unilateral WT. Elevated NLR and PIV, along with lower LMR, correlate with poorer survival. These accessible biomarkers provide a valuable, low-cost tool for risk assessment. Our optimal thresholds differed from Western adult cohorts, emphasizing the need for population-specific reference intervals in global pediatric oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, King Hussein Cancer Center, Amman 11941, Jordan.
- Department of Pediatrics, The University of Jordan, Amman 11942, Jordan.
- School of Medicine, The University of Jordan, Amman 11942, Jordan.
- Artificial Intelligence Office, King Hussein Cancer Center, Amman 11941, Jordan.
ORCID-Profile: Hadeel Halalsheh, Mohammad Alzoubi, Noor F Al-Assaf, Iyad Sultan
Zitieren
APA
Halalsheh, H., Amer, L., Alzoubi, M., Al-Assaf, N. F., Diab, A., Odeh, N., & Sultan, I. (2026). Prognostic Value of Pre-Treatment Systemic Inflammatory Markers in Pediatric Unilateral Wilms Tumor. Cancers, 18(13), 2179. https://doi.org/10.3390/cancers18132179
Vancouver
Halalsheh H, Amer L, Alzoubi M, Al-Assaf NF, Diab A, Odeh N, et al. Prognostic Value of Pre-Treatment Systemic Inflammatory Markers in Pediatric Unilateral Wilms Tumor. Cancers. 2026;18(13):2179. doi:10.3390/cancers18132179
BibTeX
@article{Halalsheh2026,
author = {Halalsheh, Hadeel and Amer, Lana and Alzoubi, Mohammad and Al-Assaf, Noor F and Diab, Adam and Odeh, Nada and Sultan, Iyad},
title = {Prognostic Value of Pre-Treatment Systemic Inflammatory Markers in Pediatric Unilateral Wilms Tumor},
journal = {Cancers},
year = {2026},
volume = {18},
number = {13},
pages = {2179},
doi = {10.3390/cancers18132179}
}
EUVIMED